Cargando…

Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation

Nuclear magnetic resonance (NMR)-based advanced lipoprotein tests have demonstrated that LDL and HDL particle numbers (LDL-P and HDL-P) are more powerful cardiovascular (CV) risk biomarkers than conventional cholesterol markers. Of interest, in people living with HIV (PLHIV), predictors of preclinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masip, Jenifer, Jorba, Rosa, López-Dupla, Miguel, Domingo, Pere, Pacheco, Yolanda María, García-Pardo, Graciano, Martínez, Esteban, Viladés, Consuelo, Veloso, Sergi, Alba, Verónica, Olona, Montserrat, Vidal, Francesc, Gómez-Bertomeu, Frederic, Peraire, Joaquim, Rull, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330003/ https://www.ncbi.nlm.nih.gov/pubmed/35897644 http://dx.doi.org/10.3390/ijms23158071

Ejemplares similares

Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
por: Yeregui, Elena, et al.
Publicado: (2022)

Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV
por: Espineira, Sonia, et al.
Publicado: (2023)

High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients
por: Yeregui, Elena, et al.
Publicado: (2020)

Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery
por: Sánchez, Alba, et al.
Publicado: (2023)

Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards
por: Veloso, Sergi, et al.
Publicado: (2010)

Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control
por: Masip, Jenifer, et al.
Publicado: (2022)

IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status
por: Ceausu, Andra, et al.
Publicado: (2019)

A baseline metabolomic signature is associated with immunological CD4(+) T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients
por: Rodríguez-Gallego, Esther, et al.
Publicado: (2018)

Differential miRNA plasma profiles associated with the spontaneous loss of HIV‐1 control: miR‐199a‐3p and its potential role as a biomarker for quick screening of elite controllers
por: Masip, Jenifer, et al.
Publicado: (2021)

HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015)

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
por: Reverté, Laia, et al.
Publicado: (2022)

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes
por: Ceperuelo-Mallafré, Victòria, et al.
Publicado: (2022)

Evolution of Serum Acute-Phase Glycoproteins Assessed by (1)H-NMR in HIV Elite Controllers
por: Malo, Ana-Irene, et al.
Publicado: (2021)

Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome
por: Perpiñan, Carles, et al.
Publicado: (2022)

Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
por: Tarancon-Diez, Laura, et al.
Publicado: (2019)

The People Living with HIV (PLHIV) Resilience Scale: Development and Validation in Three Countries in the Context of the PLHIV Stigma Index
por: Gottert, A., et al.
Publicado: (2019)

Utilidad del antígeno para el diagnóstico de infección por SARS-CoV-2 en pacientes con y sin síntomas
por: Parada-Ricart, Ester, et al.
Publicado: (2021)

Usefulness of the antigen test for diagnosing SARS-CoV-2 infection in patients with and without symptoms()
por: Parada-Ricart, Ester, et al.
Publicado: (2021)

Fucosylated N-glycans as early biomarkers of COVID-19 severity
por: Paton, Beatrix, et al.
Publicado: (2023)

Leveraging mHealth for the Treatment and Management of PLHIV
por: Kruse, Clemens Scott, et al.
Publicado: (2023)

Glycoprotein Profile Assessed by (1)H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study
por: Malo, Ana-Irene, et al.
Publicado: (2020)

Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio
por: Tarancon-Diez, Laura, et al.
Publicado: (2023)

Smokeless tobacco use and oral potentially malignant disorders among people living with HIV (PLHIV) in Pune, India: Implications for oral cancer screening in PLHIV
por: Marbaniang, Ivan, et al.
Publicado: (2022)

1274. Implementation of Pharmacist-led Medication Reconciliation in Older PLHIV
por: Karris, Maile Y, et al.
Publicado: (2022)

Mixed infection by Cryptococcus neoformans and Cryptococcus gattii and coinfection with paracoccidioidomycosis in PLHIV
por: de Faria Ferreira, Marcela, et al.
Publicado: (2022)

Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy
por: Cingolani, Antonella, et al.
Publicado: (2022)

Frailty status and associated factors among older PLHIV in Southern Ethiopia
por: Woldesemayat, Endrias Markos, et al.
Publicado: (2023)

Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia
por: Wesen, Amenu, et al.
Publicado: (2012)

Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV
por: Zhao, Juan, et al.
Publicado: (2021)

The predictors of unsuppressed viremia among PLHIV: a cross-sectional study in Ghana
por: Owusu, Lydia Boampong, et al.
Publicado: (2023)

Only connect – the role of PLHIV group networks in increasing the effectiveness of Ugandan HIV services
por: Hodgson, Ian, et al.
Publicado: (2012)

Clinico epidemiological profile of HIV - TB coinfection among PLHIV in coastal south India
por: Bhaskaran, Unnikrishnan
Publicado: (2014)

Development and validation of PozQoL: a scale to assess quality of life of PLHIV
por: Brown, Graham, et al.
Publicado: (2018)

Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight
por: S, Fathima A., et al.
Publicado: (2022)

CD4 + Count: a Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV
por: Mounika, Vakada Lakshmi, et al.
Publicado: (2023)

Trends and factors associated with initiation of HIV treatment among PLHIV in Jamaica, 2015–2019
por: Cushnie, Anya, et al.
Publicado: (2023)

The response to fasting and refeeding reveals functional regulation of lipoprotein lipase proteoforms
por: Carulla, Pere, et al.
Publicado: (2023)

Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants
por: Vidal, Francesc, et al.
Publicado: (2012)

Drivers of treatment change in PLHIV- psycho-social factors are more important than considerations of adherence
por: Pitts, Marian, et al.
Publicado: (2012)

Prevalence and Associated Factors of Depression among PLHIV in Ethiopia: Systematic Review and Meta-Analysis, 2017
por: Amare, Tadele, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mr7brsod78mis4v296m366q9en